Registered Kenya · PPB

CHLORAMPHENIRAMINE 4MG TABS

CHLORAMPHENIRAMINE

H99/353 4MG GENERIC/BIOSIMILARS

What it does

Chlorampheniramine is an antihistamine that helps relieve allergy symptoms.

Commonly used for: allergic rhinitis (hay fever), itching, runny nose, sneezing …

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
H99/353
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
CHLORAMPHENIRAMINE
Dosage form
4MG
Strength
-
Pack size
1000'S JAAR / 10 X 10'S BLISTER
Therapeutic class
GENERIC/BIOSIMILARS
Manufacturer / MAH
United Pharma
Applicant / LTR
UNITED PHARMA (K) LIMITED
Country of origin
FOREIGN
Manufacturer location
Warehouses 1,2, Universal Industrial and Logistics Park, 3 Old Mombasa Rd, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 20:15:54 · updated 2026-08-03 04:16:15

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Chlorampheniramine is an antihistamine that helps relieve allergy symptoms.

What it treats

  • allergic rhinitis (hay fever)
  • itching
  • runny nose
  • sneezing
  • hives (urticaria)

How it works

It blocks the effects of histamine, a substance in the body that causes allergic symptoms.

Who it's for

Chlorampheniramine is for adults and children experiencing allergy symptoms.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: chlorampheniramine

Chlorampheniramine is an antihistamine that is commonly used to relieve symptoms associated with allergic reactions, such as hay fever, urticaria, and allergic conjunctivitis. It works primarily by blocking the action of histamine at the H1 receptor sites, which helps to alleviate symptoms such as sneezing, itching, and runny nose. Chlorampheniramine is available in various formulations including tablets, syrups, and nasal sprays.

Indications

  • Allergic rhinitis (hay fever)
  • Urticaria (hives)
  • Allergic conjunctivitis
  • Common cold symptoms

Dosage

Children: Refer to BNF for Children for appropriate dosing information.

Adults: Refer to BNF for appropriate dosing information.

Mechanism of action

Chlorampheniramine acts as a competitive antagonist of the H1 histamine receptor. By binding to these receptors, it prevents histamine from exerting its effects, thereby reducing allergy symptoms. Additionally, it has some degree of anticholinergic activity, which can contribute to its efficacy in alleviating symptoms such as rhinorrhea.

Pharmacodynamics

Chlorampheniramine has a rapid onset of action and provides symptomatic relief from allergic conditions. Its antihistamine effects can last for several hours, making it suitable for once or twice daily dosing depending on the formulation and severity of symptoms. The anticholinergic properties may lead to sedation and dry mucous membranes, which can be beneficial in certain cases but may also pose risks in sensitive populations.

Pharmacokinetics

Chlorampheniramine is well absorbed from the gastrointestinal tract, with peak plasma concentrations occurring 1-2 hours post-administration. It is extensively metabolized in the liver, primarily through glucuronidation, and has a half-life of approximately 12-15 hours. The drug is excreted mainly in the urine, with both unchanged drug and metabolites present.

Contra-indications

  • Hypersensitivity to chlorampheniramine or any component of the formulation
  • Severe liver impairment
  • Porphyria
  • Use in neonates is contraindicated due to the risk of 'grey baby syndrome'

Adverse effects

  • Drowsiness
  • Dizziness
  • Dry mouth
  • Constipation
  • Blurred vision
  • Urinary retention
  • Allergic reactions including rash and anaphylaxis

Interactions

  • CNS depressants may enhance sedative effects
  • Monoamine oxidase inhibitors (MAOIs) can increase the risk of hypertensive crisis
  • Anticholinergic drugs may increase the risk of adverse effects
  • Alcohol may enhance drowsiness and impairment

Precautions

  • Use with caution in patients with glaucoma
  • Prostatic hypertrophy
  • Epilepsy or seizure disorders
  • Patients with cardiovascular disease
  • Elderly patients may be more sensitive to effects

Pregnancy

Chlorampheniramine is generally not recommended during pregnancy, especially in the first trimester, due to potential risks to the fetus.

Breast-feeding

Chlorampheniramine is excreted in breast milk; caution is advised in nursing mothers as it may cause sedation in infants.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

  • Tablets
  • Syrup
  • Oral suspension
  • Injectable form

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.